LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
8.39
+0.09 (1.08%)
Aug 31, 2026, 4:00 PM EDT - Market closed
LENSAR Revenue
LENSAR had revenue of $16.50M in the quarter ending June 30, 2026, with 18.37% growth. This brings the company's revenue in the last twelve months to $60.26M, up 3.26% year-over-year. In the year 2025, LENSAR had annual revenue of $58.44M with 9.24% growth.
Revenue (ttm)
$60.26M
Revenue Growth
+3.26%
P/S Ratio
1.71
Revenue / Employee
$401,760
Employees
150
Market Cap
103.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 58.44M | 4.94M | 9.24% |
| Dec 31, 2024 | 53.49M | 11.33M | 26.87% |
| Dec 31, 2023 | 42.16M | 6.81M | 19.25% |
| Dec 31, 2022 | 35.36M | 899.00K | 2.61% |
| Dec 31, 2021 | 34.46M | 8.08M | 30.62% |
| Dec 31, 2020 | 26.38M | -4.15M | -13.58% |
| Dec 31, 2019 | 30.53M | 6.14M | 25.18% |
| Dec 31, 2018 | 24.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Quanterix | 153.41M |
| Outset Medical | 117.80M |
| Pulmonx | 87.44M |
| CVRx, Inc. | 61.19M |
| Apyx Medical | 58.42M |
| electroCore | 36.97M |
| Rapid Micro Biosystems | 35.18M |
| MaxCyte | 31.05M |
LNSR News
- 11 days ago - Lensar price target raised to $10 from $9 at BTIG - TheFly
- 15 days ago - Lensar price target raised to $13 from $10 at Lake Street - TheFly
- 15 days ago - Lensar management to meet virtually with Lake Street - TheFly
- 18 days ago - LENSAR Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - LENSAR Earnings release: Q2 2026 - Filings
- 18 days ago - LENSAR Quarterly report: Q2 2026 - Filings
- 18 days ago - LENSAR® Reports Second Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 27 days ago - LENSAR Transcript: AGM 2026 - Transcripts